Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 9/20 | 0.63 |
| ▸ | MAPT | P10636 | 7/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | RAB9A | P51151 | 8/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | AHR | P35869 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26819936 | 0.82 | NPC1 (0.63) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL30608271 | 0.82 | NPC1 (0.59) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL9432830 | 0.81 | ALDH1A1 (0.51) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL10439862 | 0.80 | TTR (0.46) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL31539944 | 0.78 | MAPK14 (0.45) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL429754 | 0.78 | MAPT (1.00) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL4338832 | 0.76 | KDM4E (0.61) | SMN1; SMN2POLBAHRKDM4EALDH1A1 | |
| SCHEMBL16795004 | 0.74 | NPC1 (0.71) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL1869991 | 0.73 | NPC1 (1.00) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL16794802 | 0.72 | NPC1 (0.72) | NPC1MAPTKMT2ARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724542-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2026-04-15 | — | — | EP | disclosed |
| US-20260047265-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-4573098-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| EP-4573099-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| WO-2024251699-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | WO | disclosed |
| WO-2024038068-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-02-22 | — | — | WO | disclosed |
| WO-2024038029-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260047265-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | LEF1, DDT, MLLT1 | NPC1 4034/4885MAPT 3943/4885KMT2A 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.